JP2021527650A5 - - Google Patents

Info

Publication number
JP2021527650A5
JP2021527650A5 JP2020569890A JP2020569890A JP2021527650A5 JP 2021527650 A5 JP2021527650 A5 JP 2021527650A5 JP 2020569890 A JP2020569890 A JP 2020569890A JP 2020569890 A JP2020569890 A JP 2020569890A JP 2021527650 A5 JP2021527650 A5 JP 2021527650A5
Authority
JP
Japan
Prior art keywords
arenediyl
alkyl
cycloalkyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020569890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527650A (ja
JP7498122B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/037543 external-priority patent/WO2019241796A1/en
Publication of JP2021527650A publication Critical patent/JP2021527650A/ja
Publication of JP2021527650A5 publication Critical patent/JP2021527650A5/ja
Application granted granted Critical
Publication of JP7498122B2 publication Critical patent/JP7498122B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020569890A 2018-06-15 2019-06-17 IL-17およびRORγの阻害用のピラゾール化合物およびイミダゾール化合物 Active JP7498122B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862685742P 2018-06-15 2018-06-15
US62/685,742 2018-06-15
US201862687602P 2018-06-20 2018-06-20
US62/687,602 2018-06-20
PCT/US2019/037543 WO2019241796A1 (en) 2018-06-15 2019-06-17 Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma

Publications (3)

Publication Number Publication Date
JP2021527650A JP2021527650A (ja) 2021-10-14
JP2021527650A5 true JP2021527650A5 (cg-RX-API-DMAC7.html) 2022-06-22
JP7498122B2 JP7498122B2 (ja) 2024-06-11

Family

ID=67482968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020569890A Active JP7498122B2 (ja) 2018-06-15 2019-06-17 IL-17およびRORγの阻害用のピラゾール化合物およびイミダゾール化合物

Country Status (11)

Country Link
US (2) US11993574B2 (cg-RX-API-DMAC7.html)
EP (1) EP3807265A1 (cg-RX-API-DMAC7.html)
JP (1) JP7498122B2 (cg-RX-API-DMAC7.html)
KR (1) KR102887518B1 (cg-RX-API-DMAC7.html)
CN (2) CN112654610B (cg-RX-API-DMAC7.html)
AU (1) AU2019286531B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020025605A2 (cg-RX-API-DMAC7.html)
CO (1) CO2021000229A2 (cg-RX-API-DMAC7.html)
IL (2) IL279348B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020013692A (cg-RX-API-DMAC7.html)
WO (1) WO2019241796A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
US12559496B2 (en) 2020-04-30 2026-02-24 Janssen Pharmaceutica Nv Imidazopyrimidines as modulators of IL-17
CN114409724A (zh) * 2022-01-10 2022-04-29 南京联智医药科技有限公司 一种新的达那唑制备方法
CN118852108B (zh) * 2024-07-15 2025-09-26 南京林业大学 一种用于检测有机磷农药敌敌畏和敌百虫的新型樟脑基荧光探针及其制备方法与应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
EP1142889A1 (en) 2000-04-03 2001-10-10 Pfizer Products Inc. Pyrazole derivatives as anti-inflammatory/analgesic agents
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
WO2002047611A2 (en) 2000-11-28 2002-06-20 Board Of Regents, The University Of Texas System Cddo-compounds and combination therapies thereof
JP2005507892A (ja) 2001-09-19 2005-03-24 ファルマシア・コーポレーション 炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
EP1507541A4 (en) 2002-05-13 2009-06-03 Dartmouth College HEMMER AND APPLICATION METHOD THEREFOR
WO2004019953A1 (en) 2002-08-28 2004-03-11 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment methods
WO2006089406A1 (en) 2005-02-22 2006-08-31 Gemin X Biotechnologies Inc. Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008136838A1 (en) 2007-05-04 2008-11-13 Trustees Of Dartmouth College Novel amide derivatives of cddo and methods of use thereof
US8088824B2 (en) 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
US20090048205A1 (en) 2007-08-15 2009-02-19 Colin Meyer Combination therapy with synthetic triterpenoids and gemcitabine
ME03529B (me) 2008-01-11 2020-04-20 Reata Pharmaceuticals Inc Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
HUE033288T2 (en) 2008-04-18 2017-11-28 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
EP2279197B1 (en) 2008-04-18 2014-11-05 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
RS58392B1 (sr) 2008-04-18 2019-04-30 Reata Pharmaceuticals Inc Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
US8278311B2 (en) 2008-04-28 2012-10-02 Abbott Laboratories Substituted pyrimidine derivatives
ES2449396T3 (es) 2008-07-22 2014-03-19 Trustees Of Dartmouth College Cianoenonas monocíclicas y métodos de uso de las mismas
WO2010053817A1 (en) 2008-11-04 2010-05-14 Trustees Of Dartmouth College Betulinic acid derivatives and methods of use thereof
SG173601A1 (en) 2009-02-13 2011-09-29 Reata Pharmaceuticals Inc Delayed release, oral dosage compositions that contain amorphous cddo-me
AU2011240690C1 (en) 2010-04-12 2014-11-06 Reata Pharmaceuticals Holdings, LLC Method of treating obesity using antioxidant inflammation modulators
ES2653717T3 (es) 2010-12-17 2018-02-08 Reata Pharmaceuticals, Inc. Pirazolil- y pirimidinil-enonas tricíclicas como moduladores antioxidantes de la inflamación
EA026847B1 (ru) 2011-03-11 2017-05-31 Рита Фармасьютикалз, Инк. C4-монометилтритерпеноидные производные и способы их применения
EP2841445B1 (en) 2012-04-27 2017-06-14 Reata Pharmaceuticals, Inc. 2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
TWI630212B (zh) 2012-09-10 2018-07-21 瑞塔醫藥有限責任公司 丁香油素(oleanolic acid)之c17-烷二基與烯二基衍生物及其使用方法
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
LT2892911T (lt) 2012-09-10 2017-11-10 Reata Pharmaceuticals, Inc. Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas
US9278912B2 (en) 2012-09-10 2016-03-08 Reata Pharmaceuticals, Inc. C13-hydroxy derivatives of oleanolic acid and methods of use thereof
IL285832B2 (en) 2013-08-23 2024-01-01 Reata Pharmaceuticals Inc Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
WO2015112792A1 (en) 2014-01-24 2015-07-30 Abbvie Inc. Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
CA2975997A1 (en) * 2015-02-11 2016-08-18 Merck Sharp & Dohme Corp. Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
AU2016219109B2 (en) * 2015-02-12 2020-05-14 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant iflammation modulators
CN107709295B (zh) * 2015-05-07 2021-05-04 百时美施贵宝公司 作为RORγ调节剂的三环砜类
UA125824C2 (uk) 2016-10-24 2022-06-15 Астразенека Аб 6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
US20200077658A1 (en) 2016-12-16 2020-03-12 Basf Se Pesticidal Compounds
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
WO2018109607A1 (en) 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith

Similar Documents

Publication Publication Date Title
JP2025512474A5 (cg-RX-API-DMAC7.html)
AU2007265453B2 (en) Human protein tyrosine phosphatase inhibitors and methods of use
CA2838846C (en) Compositions and methods for treating brain edema
US20190092720A1 (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
JP2011524422A5 (cg-RX-API-DMAC7.html)
JP2020033357A5 (cg-RX-API-DMAC7.html)
JP2017518959A5 (cg-RX-API-DMAC7.html)
JP2017521496A5 (cg-RX-API-DMAC7.html)
JP2020522567A5 (cg-RX-API-DMAC7.html)
US9782420B2 (en) Method for treating eye diseases
JP2018502900A5 (cg-RX-API-DMAC7.html)
JP2015506982A5 (cg-RX-API-DMAC7.html)
CN108727378A (zh) 新型异喹啉类化合物及其医药用途
JP2025060958A (ja) インテグリン標的化リガンドとその使用
JP2018509404A5 (cg-RX-API-DMAC7.html)
RU2019116820A (ru) Антагонисты интегрина
WO2019129216A1 (zh) 一种吡啶基咪唑并苯并二氮杂卓丙酸酯化合物及其合成和应用
JP2023505434A5 (cg-RX-API-DMAC7.html)
JP2019528279A5 (cg-RX-API-DMAC7.html)
JP2021524439A5 (cg-RX-API-DMAC7.html)
JP2023548342A5 (cg-RX-API-DMAC7.html)
JP2022541545A5 (cg-RX-API-DMAC7.html)
US20080255213A1 (en) Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents
JP2025504963A5 (cg-RX-API-DMAC7.html)
JP2026503618A5 (cg-RX-API-DMAC7.html)